ONTRUZANT
As listed in the register: ONTRUZANT 150 mg, poudre pour solution à diluer pour perfusion
150 mg · poudre pour solution à diluer pour perfusion
- Prescription only
- Active substance
- Trastuzumab
- Made by
- SAMSUNG BIOEPIS NL (PAYS-BAS)
- Source
- Official label
Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.
What it is for
Mediclarum has not yet retrieved and stored the official label for this product, so none of its text is shown here. Open the official leaflet
Same active substance, strength and form in other countries
Matched on active substance, strength and kind of form only. This is not a statement that the products are equivalent or interchangeable: other ingredients, release and approved uses can differ — ask a pharmacist before swapping.
Medicine passport: one printable page to show a pharmacist abroad
United States1 matching products
European UnionNo exact match for this strength and form
Spain6 matching products
- ZERCEPAC 150 mg · polvo para concentrado para solución para perfusión2 makers
- HERZUMA 150 mg · polvo para concentrado para solución para perfusión
- OGIVRI 150 mg · polvo para concentrado para solución para perfusión
- ONTRUZANT 150 mg · polvo para concentrado para solución para perfusión
- TRAZIMERA 150 mg · polvo para concentrado para solución para perfusión
CanadaNo exact match for this strength and form
Details
| Made by | SAMSUNG BIOEPIS NL (PAYS-BAS) |
|---|---|
| Active substance | Trastuzumab |
| Strength | 150 mg |
| Form | poudre pour solution à diluer pour perfusion |
| Route | intraveineuse |
| Dispensing (as stated by the register) | médicament nécessitant une surveillance particulière pendant le traitement · prescription réservée aux spécialistes et services ONCOLOGIE MEDICALE · prescription hospitalière · liste I · la première administration doit être effectuée en milieu hospitalier · prescription réservée aux médecins compétents en CANCEROLOGIE |
| Marketed | Yes, according to the register |
| Authorisation procedure | Procédure centralisée |
| EU number | EU/1/17/1241 |
| Name in the register | ONTRUZANT 150 mg, poudre pour solution à diluer pour perfusion |
| Packs | 1 flacon en verre de 150 mg de poudre |
| CIS | 62787822 |
| CIP13 | 3400955055082 |
Source: Base de données publique des médicaments · 2026-09-30 · not reviewed by a clinician
Source : Base de données publique des médicaments (ANSM / Ministère de la Santé), sous Licence Ouverte. Reuse terms: Licence Ouverte / Open Licence (Etalab).
Other strengths and forms
2 products are sold under this name. Grouped by form; a number on a strength means several companies make it.
- poudre pour solution à diluer pour perfusion2 products
- 150 mg
- 420 mg
Same active substance
These contain the same substance. That does not mean one can replace another — ask a pharmacist.